{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:02:09Z","timestamp":1753887729431,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Adrenocortical carcinoma (ACC) is a rare malignancy with a prevalence of 1 to 2 cases\/million\/year. The diagnosis depends upon endocrine workup followed by imaging with CT, MRI, and <jats:sup>18<\/jats:sup>F-FDG PET\/CT. The treatment includes surgical resection, debulking surgery, chemotherapy, and radiotherapy. However, patients do not respond well to any of the available therapies. We present noninvasive imaging of histopathology-proven ACC patients using <jats:sup>68<\/jats:sup>Ga-DOTAGA-IAC PET\/CT, specific for integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub>. <jats:sup>68<\/jats:sup>Ga-DOTAGA-IAC PET\/CT 45 minutes after IV injection showed a decent tumor-to-background ratio and could be used as a promising radiotracer for metastatic and recurrent ACC.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004497","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T16:02:57Z","timestamp":1673020977000},"page":"e95-e98","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["68Ga-DOTAGA-IAC PET\/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Somit","family":"Pandey","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Walia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejal","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Satz","sequence":"additional","affiliation":[{"name":"Advanced Innovative Partners, Inc, Miami, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors","volume":"179","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11912-019-0773-7","article-title":"Management of adrenocortical carcinoma","volume":"21","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","year":"1971","journal-title":"N Engl J Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"bib5-20250621","first-page":"132641","article-title":"Tumor angiogenesis: insights and innovations","volume":"2010","year":"2010","journal-title":"J Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.2528","article-title":"Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma","volume":"218","year":"2009","journal-title":"J Pathol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.nucmedbio.2007.02.002","article-title":"Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice","volume":"34","year":"2007","journal-title":"Nucl Med Biol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1016\/j.bmcl.2012.07.024","article-title":"Synthesis and characterization of \u03b1v\u03b23-targeting peptidomimetic chelate conjugates for PET and SPECT imaging","volume":"22","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"bib9-20250621","first-page":"152","article-title":"First-in-human study demonstrating tumor-angiogenesis by PET\/CT imaging with (68)Ga-NODAGA-THERANOST, a high-affinity peptidomimetic for \u03b1v\u03b23 integrin receptor targeting","volume":"30","year":"2015","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:44Z","timestamp":1750536104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004497"}},"subtitle":["A Case Series"],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004497","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}